Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status
- PMID: 12198537
- DOI: 10.1038/418934a
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status
Abstract
Genes of the RAF family encode kinases that are regulated by Ras and mediate cellular responses to growth signals. Activating mutations in one RAF gene, BRAF, have been found in a high proportion of melanomas and in a small fraction of other cancers. Here we show that BRAF mutations in colorectal cancers occur only in tumours that do not carry mutations in a RAS gene known as KRAS, and that BRAF mutation is linked to the proficiency of these tumours in repairing mismatched bases in DNA. Our results not only provide genetic support for the idea that mutations in BRAF and KRAS exert equivalent effects in tumorigenesis, but also emphasize the role of repair processes in establishing the mutation spectra that underpin human cancer.
Similar articles
-
RAS/RAF mutation and defective DNA mismatch repair in endometrial cancers.Am J Obstet Gynecol. 2004 Apr;190(4):935-42. doi: 10.1016/j.ajog.2004.01.017. Am J Obstet Gynecol. 2004. PMID: 15118616
-
Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation.Genes Chromosomes Cancer. 2004 Feb;39(2):138-42. doi: 10.1002/gcc.10310. Genes Chromosomes Cancer. 2004. PMID: 14695993
-
Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.Cancer Res. 2002 Nov 15;62(22):6451-5. Cancer Res. 2002. PMID: 12438234
-
Colorectal cancer: a multipathway disease.Crit Rev Oncog. 2006 Dec;12(3-4):273-87. doi: 10.1615/critrevoncog.v12.i3-4.50. Crit Rev Oncog. 2006. PMID: 17425506 Review.
-
[Genetic steps in colorectal cancer].Nihon Rinsho. 1996 Apr;54(4):1072-7. Nihon Rinsho. 1996. PMID: 8920676 Review. Japanese.
Cited by
-
Colorectal Cancer Biomarkers: Where Are We Now?Biomed Res Int. 2015;2015:149014. doi: 10.1155/2015/149014. Epub 2015 May 27. Biomed Res Int. 2015. PMID: 26106599 Free PMC article. Review.
-
CDX2 is an amplified lineage-survival oncogene in colorectal cancer.Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):E3196-205. doi: 10.1073/pnas.1206004109. Epub 2012 Oct 29. Proc Natl Acad Sci U S A. 2012. PMID: 23112155 Free PMC article.
-
Precision oncology in metastatic colorectal cancer - from biology to medicine.Nat Rev Clin Oncol. 2021 Aug;18(8):506-525. doi: 10.1038/s41571-021-00495-z. Epub 2021 Apr 16. Nat Rev Clin Oncol. 2021. PMID: 33864051 Review.
-
Clinical and molecular detection of inherited colorectal cancers in northeast Italy: a first prospective study of incidence of Lynch syndrome and MUTYH-related colorectal cancer in Italy.Tumour Biol. 2012 Jun;33(3):857-64. doi: 10.1007/s13277-011-0312-0. Epub 2012 Jan 26. Tumour Biol. 2012. PMID: 22278153
-
Prognostic impact of mutation profiling in patients with stage II and III colon cancer.Sci Rep. 2016 Apr 14;6:24310. doi: 10.1038/srep24310. Sci Rep. 2016. PMID: 27074743 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
